Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
clinical trial
New GLP-1 Pill Orforglipron Outperforms Rybelsus in Trial
Orforglipron, a new GLP-1 pill, outperforms Rybelsus in blood sugar control and weight loss in late-stage Type 2 diabetes trial.
